Synonyms: | |
Status: | Approved |
Entry Type: | Small molecule |
Molecule Category: | Parent |
ATC: | G04BE04 |
UNII: | 2Y49VWD90Q |
InChI Key | BLGXFZZNTVWLAY-SCYLSFHTSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C21H26N2O3 |
Molecular Weight | 354.45 |
AlogP | 2.65 |
Hydrogen Bond Acceptor | 4.0 |
Hydrogen Bond Donor | 2.0 |
Number of Rotational Bond | 1.0 |
Polar Surface Area | 65.56 |
Molecular species | NEUTRAL |
Aromatic Rings | 2.0 |
Heavy Atoms | 26.0 |
Primary Target | |
---|---|
α2A-adrenoceptor | |
α2B-adrenoceptor | |
α2C-adrenoceptor |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Erectile Dysfunction | 4 | D007172 | ClinicalTrials |
Diabetes Mellitus, Type 2 | 2 | D003924 | ClinicalTrials |
Cocaine-Related Disorders | 2 | D019970 | ClinicalTrials |
Alcoholism | 2 | D000437 | ClinicalTrials |
Stress Disorders, Post-Traumatic | 2 | D013313 | ClinicalTrials |
Opioid-Related Disorders | 2 | D009293 | ClinicalTrials |
Opioid-Related Disorders | 2 | D009293 | ClinicalTrials |
Hypotension, Orthostatic | 1 | D007024 | ClinicalTrials |
Marijuana Abuse | 1 | D002189 | ClinicalTrials |
Orthostatic Intolerance | 1 | D054971 | ClinicalTrials |
Parkinson Disease | 0 | D010300 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 146-48-5 |
ChEBI | 10093 |
ChEMBL | CHEMBL15245 |
DrugBank | DB01392 |
DrugCentral | 3659 |
EPA CompTox | DTXSID9040130 |
FDA SRS | 2Y49VWD90Q |
Human Metabolome Database | HMDB0015464 |
Guide to Pharmacology | 102 |
KEGG | C09256 |
PharmGKB | PA451946 |
PubChem | 8969 |
SureChEMBL | SCHEMBL33954 |
ZINC | ZINC000003860825 |